Form D — Enveric Biosciences, Inc.
0000890821-25-000004 · filed Oct 3, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- —
- Reported amount sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Enveric Biosciences, Inc.
- CIK
- 890821
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR
CAMBRIDGE, Massachusetts 02142 - Phone
- (617) 444-8400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joseph E. Tucker · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Kevin M. Coveney · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Michael D. Webb · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
George W. Kegler · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Marcus Schabacker · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Frank Pasqualone · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Sheila DeWitt · DirectorCambridge, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗